Comparison of dipeptidyl peptidase-4 inhibitors and pioglitazone combination therapy versus pioglitazone monotherapy in type 2 diabetes: A system review and meta-analysis (Q60054208)

From Wikidata
Jump to navigation Jump to search
No description defined
edit
Language Label Description Also known as
English
Comparison of dipeptidyl peptidase-4 inhibitors and pioglitazone combination therapy versus pioglitazone monotherapy in type 2 diabetes: A system review and meta-analysis
No description defined

    Statements

    0 references
    7 references
    24 March 2019
    2 August 2019
    2 October 2019
    30 January 2021
    4 February 2021
    0 references
    Comparison of dipeptidyl peptidase-4 inhibitors and pioglitazone combination therapy versus pioglitazone monotherapy in type 2 diabetes: A system review and meta-analysis (English)
    0 references
    1 reference
    2 August 2019
    3 references
    2 August 2019
    2 October 2019
    4 February 2021
    1 reference
    2 October 2019
    Ben Wang
    0 references
    Yan Sun
    0 references
    Yiquan Sang
    0 references
    Xuekui Liu
    0 references
    Jun Liang
    0 references
    November 2018
    0 references
    1 November 2018
    97
    0 references
    e12633
    0 references
    46
    0 references

    Identifiers

    0 references
    0 references
     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit